Collins Stewart
http://www.collins-stewart.com/index.aspCollins Stewart is an independent investment banking group.
View Older Stories View More Recent Stories
-
Collins Stewart Starts Aaron's (AAN) at Buy; Our Model Projects EPS Will Increase at 5-Yr CAGR of 11%
-
Collins Stewart Starts Rent-A-Center (RCII) at Buy; Shares Appear Attractively Valued
-
Collins Stewart Starts Big Lots (BIG) at Buy; Recent Pullback Creates Opportunity
-
Collins Stewart Starts Bed Bath and Beyond (BBBY) at Buy; Industry Leadership Drives Outsized Returns
-
Collins Stewart Starts Williams-Sonoma (WSM) at Buy; Dominates the e-Commerce Channel in Home Furnishings
-
Collins Stewart Starts MakeMyTrip (MMYT) at Buy; Leader in Indian Online Travel, With Multiple Growth Drivers
-
Collins Stewart Raises Price Target on American Tower (AMT), Sees 20% Dividend Growth Over Next 3-Years
-
Collins Stewart Upgrades Deutsche Bank (DB) to Buy
-
Collins Stewart Cuts Price Target on Avnet (AVT) After Attending Analyst Meeting
-
Collins Stewart Upgrades Daqo New Energy (DQ) to Neutral; Negative Thesis has Played Out
-
Notable Analyst Rating Changes 12/09: (WFR) (ESL) (ALU) Upgraded; (COST) (FNFG) (IVR) Downgraded
-
Collins Stewart Upgrades MEMC Electronic Materials (WFR) to Buy; SunEdison and Valuation
-
First Solar (FSLR) Ramps On Topaz Sale; Deal Reduces Risk to Estimates
-
Collins Stewart Starts Rackspace (RAX) at Neutral; Strong Growth From Cloud, But Fully Priced In
-
Unusual 11 Mid-Day Movers 12/02: (VISN) (NCTY) (MITL) Higher; (CSIQ) (UVV) (BIG) Lower
-
Collins Stewart Maintains a 'Neutral' on Sprint (S); Clearwire Drama Continues
-
Hospira (HSP) May Find Itself a Takeover Target
-
Collins Stewart Starts Anthera Pharma (ANTH) at Buy; Rare Risk/Reward Opportunity
-
Collins Stewart Upgrades Statoil ASA (STO) to Buy
-
Collins Stewart Starts Sagent Pharmaceuticals (SGNT) at Buy; Potential Earnings Upside is Underappreciated
-
Collins Stewart Cuts Price Target on Canadian Solar (CSIQ), Volume Trends Still Above Peers
-
Collins Stewart Reports Hanwha SolarOne (HSOL) Should Buy Outstanding Stock and Go Private
-
Notable Analyst Rating Changes 11/25: (CRIC) (VIP) (AEG) (AIV) Downgraded
-
Collins Stewart Starts CGG Veritas (CGV) at Hold
-
Collins Stewart Starts ZIOPHARM Oncology (ZIOP) at Buy; Palifosfamide Poised to be Standard-of-Care in mSTS
-
Collins Stewart Starts BioMimetic Therapeutics (BMTI) at Buy, Price Target Calls for 143% Upside
-
Notable Analyst Rating Changes 11/21: (WDC) (MS) (HOTT) Upgraded; (RIMM) (TGT) (WAG) Downgraded
-
Collins Stewart Upgrades Morgan Stanley (MS) to Buy
-
Notable Analyst Rating Changes 11/17: (AMT) (MU) (LULU) Upgraded; (MRVL) (NTAP) (RMBS) Downgraded
-
Collins Stewart Downgrades NetApp (NTAP) to Hold; Second Miss in a Row Raises Concerns
-
Dell (DELL) Beats Q3 Views, But Lightens Outlook; Analysts Comment on Results
-
Notable Analyst Rating Changes 11/16: (RIMM) (FBC) (ADSK) Upgraded; (THC) (CIM) (DELL) Downgraded
-
Collins Stewart Starts Tech Data (TECD) at Neutral
-
Collins Stewart Starts Ingram Micro (IM) at Neutral
-
Collins Stewart Starts Avnet (AVT) at Neutral
-
Collins Stewart Starts Arrow Electronics (ARW) at Neutral
-
Collins Stewart Starts SYNNEX Corp. (SNX) at Buy
-
Q3 Preview: Analysts Look Past Results to Guidance in an Effort to Value Dell (DELL)
-
Collins Stewart Cuts Price Targets on JinkoSolar Holding (JKS), Sees Profitability in Fiscal 2013
-
Collins Stewart Cuts Price Targets on Dolby Laboratories (DLB) Ahead of Earnings, Lowers Expectations
-
Collins Stewart Starts Cadence Pharma (CADX) at Buy; Ofirmev Sales Potential Underappreciated
-
Notable Analyst Rating Changes 11/09: (LYG) (HRB) (MCK) Upgraded; (ADSK) (PRU) (NVDA) Downgraded
-
Collins Stewart Downgrades Rovi Corp. (ROVI) to Neutral; Lowers Outlook for 2011/2012
-
Collins Stewart Downgrades Sanofi-Aventis (SNY) to Sell
-
Collins Stewart Downgrades Novartis (NVS) to Hold
-
Collins Stewart Upgrades Fabrinet (FN) to Buy; Flooding Subsiding
-
Collins Stewart Maintains a 'Buy' on OpenTable (OPEN); Reducing 2012 Estimates and Price Target
-
Collins Stewart Cuts Price Targets on Cablevision (CVC) Following the Roughly 17% Sell-Off
-
Collins Stewart Sees Some Softness In OpenTable (OPEN) 3Q, But Says Shares Should Be Bought
-
Collins Stewart Reiterates a 'Buy' on Baidu (BIDU); Strong Beat and Guidance - Raising Estimates & PT; Sector Top Pick

